Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight

scientific article

Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/AJH.23530
P698PubMed publication ID23828018

P2093author name stringJaroslaw P Maciejewski
Mikkael A Sekeres
Sudipto Mukherjee
Matt E Kalaycio
Ramon V Tiu
Anjali S Advani
Marc Earl
Candice M Wenzell
Jun-Yen Yeh
Erika M Gallagher
Karissa N Kusick
P2860cites workPretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Q28209814
Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obeseQ33303164
Actual body weight for determining doses of chemotherapy in obese cancer patients: evaluation of treatment tolerabilityQ33358496
Effects of obesity on pharmacokinetics implications for drug therapyQ34053786
Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelinesQ34459673
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guidelineQ34637194
Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).Q34856664
Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemiaQ35671452
Is obesity a prognostic factor for acute myeloid leukemia outcome?Q35749864
Mortality in overweight and underweight children with acute myeloid leukemiaQ36006255
Weight-based chemotherapy dosing in obese patients with cancer: back to the futureQ36095287
Impact of body-mass index on the outcome of adult patients with acute myeloid leukemiaQ36216242
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaQ40543180
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patientsQ47201592
P433issue10
P921main subjectobesityQ12174
leukemiaQ29496
acute myeloid leukemiaQ264118
chemotherapyQ974135
P304page(s)906-909
P577publication date2013-08-30
P1433published inAmerican Journal of HematologyQ4744246
P1476titleOutcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight
P478volume88